MY137408A - Hepatitis a virus vaccine - Google Patents
Hepatitis a virus vaccineInfo
- Publication number
- MY137408A MY137408A MYPI93001552A MYPI9301552A MY137408A MY 137408 A MY137408 A MY 137408A MY PI93001552 A MYPI93001552 A MY PI93001552A MY PI9301552 A MYPI9301552 A MY PI9301552A MY 137408 A MY137408 A MY 137408A
- Authority
- MY
- Malaysia
- Prior art keywords
- hav
- hepatitis
- protein
- yield
- virus vaccine
- Prior art date
Links
- 229940124870 Hepatitis A virus vaccine Drugs 0.000 title 1
- 241000709721 Hepatovirus A Species 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92687392A | 1992-08-07 | 1992-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY137408A true MY137408A (en) | 2009-01-30 |
Family
ID=25453825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI93001552A MY137408A (en) | 1992-08-07 | 1993-08-06 | Hepatitis a virus vaccine |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR950703054A (enrdf_load_html_response) |
| HR (1) | HRP931103A2 (enrdf_load_html_response) |
| IL (1) | IL106609A0 (enrdf_load_html_response) |
| MY (1) | MY137408A (enrdf_load_html_response) |
| TW (1) | TW259708B (enrdf_load_html_response) |
| YU (1) | YU53193A (enrdf_load_html_response) |
-
1993
- 1993-08-05 YU YU53193A patent/YU53193A/sh unknown
- 1993-08-06 IL IL93106609A patent/IL106609A0/xx unknown
- 1993-08-06 HR HRP931103AA patent/HRP931103A2/hr not_active Application Discontinuation
- 1993-08-06 KR KR1019950700576A patent/KR950703054A/ko not_active Withdrawn
- 1993-08-06 TW TW082106295A patent/TW259708B/zh active
- 1993-08-06 MY MYPI93001552A patent/MY137408A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW259708B (enrdf_load_html_response) | 1995-10-11 |
| YU53193A (sh) | 1996-10-09 |
| IL106609A0 (en) | 1993-12-08 |
| KR950703054A (ko) | 1995-08-23 |
| HRP931103A2 (hr) | 1995-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1994003589A3 (en) | Hepatitis a virus vaccine | |
| Höglund et al. | ISCOMs and immunostimulation with viral antigens | |
| Lawton et al. | Biosynthesis and purification of V and W antigen in Pasteurella pestis | |
| CA1252720A (en) | Vaccine for cytomegalovirus | |
| Morgan et al. | Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines | |
| EP0339667A2 (en) | Hepatitis A,B,-combined adjuvanted vaccine | |
| RU94042722A (ru) | Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина | |
| Pay et al. | Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process | |
| Epstein et al. | Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals | |
| Ogra et al. | Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines | |
| EP0342860A3 (en) | Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use | |
| Chavali et al. | Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection | |
| CA2217522A1 (en) | Isolated frpb nucleic acid molecule and vaccine | |
| US5276142A (en) | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis | |
| MY137408A (en) | Hepatitis a virus vaccine | |
| ES466359A1 (es) | Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia. | |
| Schilperoort et al. | Agrobacterium tumefaciens cross-reacting antigens in sterile crown-gall tumors | |
| US3769415A (en) | Method of preparing a killed vaccine for oral use | |
| Berinstein et al. | Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall | |
| CA1126155A (en) | Immunogenic cell envelope preparations | |
| IE873268L (en) | Conjugate vaccine | |
| AU5573196A (en) | A pluripotent vaccine against enveloped viruses | |
| IL86675A (en) | Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same | |
| JPH0751513B2 (ja) | Ａ型肝炎ワクチン | |
| Cole Jr et al. | Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells |